Eli Lilly and Company is a global pharmaceutical company based in Indianapolis, Indiana, that has been serving the health care needs of people around the world for more than 140 years. Founded in 1876 by Colonel Eli Lilly, the company has grown to become one of the largest pharmaceutical companies in the world, with operations in more than 70 countries and products available in more than 125 countries.
The company’s commitment to research and development has resulted in a long list of innovations. Eli Lilly has developed a wide range of drugs for the treatment of various diseases, including diabetes, cancer, and Alzheimer’s. The company’s commitment to innovation extends beyond its products to its approach to doing business. For example, Eli Lilly has developed and implemented a number of initiatives to improve access to medicines in developing countries, including the Lilly MDR-TB Partnership, which provides free treatment to people suffering from multidrug-resistant tuberculosis.
In addition to its commitment to research and development, Eli Lilly is also committed to the Indianapolis community. The company has invested more than $1 billion in its Indianapolis operations, which include research and development facilities, manufacturing sites, and corporate offices. The company employs more than 7,000 people in the Indianapolis area, making it one of the area’s largest employers.
In addition to its commitment to the Indianapolis community, Eli Lilly has a long history of philanthropic giving. The company has donated millions of dollars to area non-profits, including the Indianapolis Symphony Orchestra, the Indianapolis Museum of Art, and the Children’s Museum of Indianapolis. The company has also established a number of charitable foundations, including the Eli Lilly and Company Foundation, the Lilly Endowment, and the Lilly Diabetes Research Foundation. These foundations provide funding for a variety of programs and initiatives, including medical research, education, and community development.
Eli Lilly’s commitment to Indianapolis and to the global community has earned the company numerous awards and recognitions, including the Indianapolis Business Journal’s “Corporate Citizen of the Year” award in 2013 and the “Best Employer” award from the Indianapolis Chamber of Commerce in 2014.
In addition to its commitment to research and development, philanthropy, and the local community, Eli Lilly has also taken a leadership role in advocating for public policy changes that will improve access to medicines for people around the world. The company has been a vocal advocate for the expansion of the Medicare Part D prescription drug program and for the passage of the Affordable Care Act. The company has also been a leader in the fight against counterfeit medicines, working with governments and international organizations to reduce the availability of fake medicines.
Eli Lilly’s commitment to research and development, philanthropy, and the Indianapolis community has made the company a leader in the global pharmaceutical industry. The company’s commitment to innovation, philanthropy, and public policy advocacy has also earned it the respect of people around the world. With its long history of innovation, philanthropy, and commitment to the Indianapolis community, Eli Lilly and Company has established itself as a leader in the global pharmaceutical industry and a pillar of the Indianapolis community.